What’s the future of weight loss drugs? BBCRace intensifies to lead next wave of obesity drugs as trial results loom Pharma VoiceEASO Update Gives Clearer Roles for Tirzepatide, Semaglutide MedscapeFramework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update NatureECO 2026: targeting organs, not just weight, defines next wave of obesity therapy Clinical Trials Arena
